SHSE:600613's Days Payable is ranked worse than 57.16% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs SHSE:600613: 79.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shenqi Pharmaceutical Investment Management Co Days Payable Chart
Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shenqi Pharmaceutical Investment Management Co Days Payable vs Drug Manufacturers Industry
Shanghai Shenqi Pharmaceutical Investment Management Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) has a Days Payable of 93.72 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. This is 19% above median its historical median of 78.65. Over the past decade, Shanghai Shenqi Pharmaceutical Investment Management Co's Days Payable has ranged from 60.85 to 88.65. According to the industry distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #527 out of 922 companies in the Drug Manufacturers industry, placing it in the top 57.2%.
Is Shanghai Shenqi Pharmaceutical Investment Management Co's Days Payable too high?
Shanghai Shenqi Pharmaceutical Investment Management Co's current Days Payable of 93.72 is 19% above median its 10-year median of 78.65. Over the past 10 years, this metric has ranged from a low of 60.85 to a high of 88.65. The Drug Manufacturers industry median Days Payable is 90.61. Shanghai Shenqi Pharmaceutical Investment Management Co's value of 93.72 is 3.4% above this industry median. Based on the distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #527 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shanghai Shenqi Pharmaceutical Investment Management Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shenqi Pharmaceutical Investment Management Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shanghai Shenqi Pharmaceutical Investment Management Co ranks #527 out of 922 companies for Days Payable. This places Shanghai Shenqi Pharmaceutical Investment Management Co in the lower half of its industry. The industry median Days Payable is 90.61. Shanghai Shenqi Pharmaceutical Investment Management Co's value of 93.72 is 3.4% above this benchmark. Historically, Shanghai Shenqi Pharmaceutical Investment Management Co's own Days Payable has ranged from 60.85 to 88.65 over the past decade. While the company's 10-year median is 78.65 vs. the industry median of 90.61, Shanghai Shenqi Pharmaceutical Investment Management Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Shenqi Pharmaceutical Investment Management Co's current Days Payable of 93.72 is 3.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Shenqi Pharmaceutical Investment Management Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Shenqi Pharmaceutical Investment Management Co's current Days Payable is 93.72, which is 19% above median its own 10-year median of 78.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shenqi Pharmaceutical Investment Management Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.44, compared to a current price of ¥4.82 — trading 11.4% below its estimated fair value. The current Days Payable is 93.72, which is 19% above median its 10-year median of 78.65 and 3.4% above the Drug Manufacturers industry median of 90.61. Shanghai Shenqi Pharmaceutical Investment Management Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613), the current Days Payable is 93.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be undervalued.
The current stock price of ¥4.82 is trading 11.4% below its estimated GF Value™ of ¥5.44.
GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Modestly Undervalued.
Key valuation signals for SHSE:600613:
Days Payable: 93.72 (19% above median its 10-year median of 78.65)
GF Value™: ¥5.44 vs. price of ¥4.82 (11.4% below fair value)
Industry Position: 3.4% above the Drug Manufacturers median (#527 of 922)
No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shenqi Pharmaceutical Investment Management Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600613 has been successfully added to your 
